ITM Power: Balancing a Director's Confidence with a Pending Subsidy Ruling
Published on 07/09/2026 at 17:30 | Redaktion boerse-global.de
Warren East, the non-executive director of ITM Power, snapped up 172,000 shares on 4 July, a purchase worth several hundred thousand pounds at current prices. The market, however, has yet to catch the same enthusiasm. The stock closed at €1.36 on Wednesday, down 10.75% over the past 30 days and 47.17% below its 52-week high of €2.58 reached on 29 May. The divergence between insider conviction and share price performance underscores the uncertainty hanging over the hydrogen electrolyser maker.
That uncertainty centres on a £86.5 million government-backed funding package. The Department for Energy Security and Net Zero has agreed to provide £46.5 million as a grant, with another £40 million coming as equity from Great British Energy. But the £46.5 million grant still requires clearance from the Subsidy Advice Unit of the Competition and Markets Authority (CMA). The regulatory review is not yet complete, meaning the final investment decision for the automated "Chronos" production line in Sheffield remains pending.
The Chronos line is central to ITM Power's long-term strategy. When operational from 2028, it is expected to deliver one gigawatt of annual capacity for the company's next-generation electrolyser stack. The new design halves the number of components compared with its predecessor while doubling power density to 2.5 megawatts per square metre. Chief Executive Dennis Schulz described the funding approval as a "decisive step" for both the company and the UK's energy transition, with the goal of turning Sheffield into a global hydrogen manufacturing hub.
Should investors sell immediately? Or is it worth buying ITM Power?
While the Chronos project awaits its regulatory green light, ITM Power is making operational headway on other fronts. The company reported a record first-half revenue of £18 million, the highest in its history, and ended the previous reporting period with an order book of £152 million – a figure that management says includes a growing share of profitable contracts. Existing projects include a 120-megawatt scheme with Uniper, the 20-megawatt MorGen Energy project, and a 15-megawatt venture in Cromarty with Protium. A partnership with Rheinmetall on the so-called "Giga PtX" project for synthetic fuels targeting defence and industrial applications is also a key component of recent analyst assessments.
Analysts at Berenberg recently raised their price target for ITM Power to 200 pence (roughly €2.35), citing the opening of new end markets as a growth driver. The upgrade came despite the stock's recent slide and the company's continued operating losses. Observers note that ITM Power's debt remains relatively low and that its contract quality has improved, even if the gap between technology readiness and large-scale series production has yet to close.
The share's technical indicators suggest a neutral rather than distressed position. The 14-day relative strength index is hovering near 42 – a reading that signals neither overbought nor oversold conditions. The stock trades 21.47% below its 50-day moving average of €1.73 but remains comfortably above the 200-day average of €1.07. The annualised 30-day volatility of 107.31% reflects the elevated risk that still characterises hydrogen technology stocks.
ITM Power's market capitalisation stands at €914.36 million, keeping it among the larger players in the electrolyser sector. But the road to profitability will depend on scaling up the Chronos line and securing regulatory sign-off on the £46.5 million grant. Until the CMA's Subsidy Advice Unit delivers its verdict, the stock is likely to remain caught between promising operational progress and a critical unresolved milestone.
Ad
ITM Power Stock: New Analysis - 9 July
Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
